Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GOLD
2801
Gold.com Inc
GOLD
$1.18B
| $515K | ﹤0.01% |
64,200
-19,000
| -23% | -$160K |
2016 Q1
2 quarters
|
|
2802
Arcos Dorados Holdings
ARCO
$1.64B
| $515K | ﹤0.01% |
+100,357
| New | +$521K |
2016 Q3
0 quarters
|
|
|
STRR
2803
Star Equity Holdings
STRR
$38.1M
| $515K | ﹤0.01% |
33,410
+3,920
| +13% | +$73.1K |
2013 Q2
13 quarters
|
|
|
MCF
2804
DELISTED
Contango Oil & Gas Co.
MCF
| $515K | ﹤0.01% |
50,400
-101,864
| -67% | -$1.05M |
2015 Q1
6 quarters
|
|
|
ENG
2805
DELISTED
ENGlobal Corp
ENG
| $514K | ﹤0.01% |
42,579
+3,591
| +9% | +$39.6K |
2013 Q2
13 quarters
|
|
|
CCM
2806
Concord Medical Services
CCM
$16.8M
| $513K | ﹤0.01% |
12,890
-510
| -4% | -$21.4K |
2013 Q2
13 quarters
|
|
2807
Wolfspeed
WOLF
$1.62B
| $512K | ﹤0.01% |
19,900
-2,900
| -13% | -$74.9K |
2016 Q2
1 quarter
|
|
2808
MediWound
MDWD
$162M
| $511K | ﹤0.01% |
9,486
+1,372
| +17% | +$73K |
2015 Q2
5 quarters
|
|
2809
John Wiley & Sons Class A
WLY
$2.52B
| $511K | ﹤0.01% |
9,900
-48,300
| -83% | -$2.65M |
2015 Q2
5 quarters
|
|
2810
Ultralife
ULBI
$104M
| $509K | ﹤0.01% |
123,844
-11,356
| -8% | -$49.9K |
2013 Q2
13 quarters
|
|
|
CORV
2811
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $509K | ﹤0.01% |
162,613
+72,400
| +80% | +$264K |
2013 Q2
13 quarters
|
|
|
ARCX
2812
DELISTED
Arc Logistics Partners LP
ARCX
| $507K | ﹤0.01% |
33,703
-11,997
| -26% | -$177K |
2016 Q2
1 quarter
|
|
|
STRS
2813
DELISTED
STRATUS PPTYS INC
STRS
| $505K | ﹤0.01% |
20,700
-28,900
| -58% | -$579K |
2013 Q4
11 quarters
|
|
2814
Dorchester Minerals
DMLP
$1.46B
| $504K | ﹤0.01% |
32,700
-30,300
| -48% | -$456K |
2013 Q2
13 quarters
|
|
|
HMLP
2815
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $501K | ﹤0.01% |
26,600
-1,900
| -7% | -$35.1K |
2016 Q2
1 quarter
|
|
|
CDTX
2816
DELISTED
Cidara Therapeutics
CDTX
| $498K | ﹤0.01% |
2,175
+835
| +62% | +$193K |
2016 Q2
1 quarter
|
|
|
VRTV
2817
DELISTED
VERITIV CORPORATION
VRTV
| $497K | ﹤0.01% |
+9,900
| New | +$458K |
2016 Q3
0 quarters
|
|
|
EEI
2818
DELISTED
Ecology and Environment
EEI
| $492K | ﹤0.01% |
49,700
+3,800
| +8% | +$38.6K |
2014 Q3
8 quarters
|
|
|
OCRX
2819
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $491K | ﹤0.01% |
185,800
+16,700
| +10% | +$41.7K |
2015 Q2
5 quarters
|
|
|
AV
2820
DELISTED
Aviva Plc
AV
| $490K | ﹤0.01% |
42,600
+30,200
| +244% | +$328K |
2016 Q2
1 quarter
|
|
2821
Educational Development Corp
EDUC
$11.1M
| $489K | ﹤0.01% |
85,862
-17,200
| -17% | -$105K |
2014 Q4
7 quarters
|
|
|
GOGL
2822
DELISTED
Golden Ocean Group
GOGL
| $489K | ﹤0.01% |
120,700
+41,540
| +52% | +$155K |
2016 Q1
2 quarters
|
|
2823
Acco Brands
ACCO
$414M
| $487K | ﹤0.01% |
50,547
-301,100
| -86% | -$3.09M |
2015 Q4
3 quarters
|
|
|
HWCC
2824
DELISTED
Houston Wire & Cable Company
HWCC
| $487K | ﹤0.01% |
78,600
+10,600
| +16% | +$61.3K |
2015 Q4
3 quarters
|
|
2825
Cineverse
CNVS
$45.4M
| $486K | ﹤0.01% |
11,963
+4,901
| +69% | +$172K |
2013 Q2
13 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.